Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE Study

Title: Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE Study
Authors: Deidda M.; Noto A.; Dessalvi C. C.; Andreini D.; Andreotti F.; Ferrannini E.; Latini R.; Maggioni A. P.; Magnoni M.; Mercuro G.
Contributors: M. Deidda; A. Noto; C.C. Dessalvi; D. Andreini; F. Andreotti; E. Ferrannini; R. Latini; A.P. Maggioni; M. Magnoni; G. Mercuro
Publisher Information: MDPI
Publication Year: 2022
Collection: The University of Milan: Archivio Istituzionale della Ricerca (AIR)
Subject Terms: Atherosclerosi; Cardiovascular risk factor; Coronary artery disease; Metabolomics; Settore MED/11 - Malattie dell'Apparato Cardiovascolare
Description: Traditional cardiovascular (CV) risk factors (RFs) and coronary artery disease (CAD) do not always show a direct correlation. We investigated the metabolic differences in a cohort of patients with a high CV risk profile who developed, or did not develop, among those enrolled in the Coronary Atherosclerosis in Outlier Subjects: Protective and Novel Individual Risk Factors Evaluation (CAPIRE) study. We studied 112 subjects with a high CV risk profile, subdividing them according to the presence (CAD/High-RFs) or absence of CAD (No-CAD/High-RFs), assessed by computed tomography angiography. The metabolic differences between the two groups were identified by gas chromatography-mass spectrometry. Characteristic patterns and specific metabolites emerged for each of the two phenotypic groups: high concentrations of pyruvic acid, pipecolic acid, p-cresol, 3-aminoisobutyric acid, isoleucine, glyceric acid, lactic acid, sucrose, phosphoric acid, trimethylamine-N-oxide, 3-hydroxy-3-methylglutaric acid, erythritol, 3-hydroxybutyric acid, glucose, leucine, and glutamic acid; and low concentrations of cholesterol, hypoxanthine, glycerol-3-P, and cysteine in the CAD/High-RFs group vs the No-CAD/High-RFs group. Our results show the existence of different metabolic profiles between patients who develop CAD and those who do not, despite comparable high CV risk profiles. A specific cluster of metabolites, rather than a single marker, appears to be able to identify novel predisposing or protective mechanisms towards CAD beyond classic CVRFs.
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/35208197; info:eu-repo/semantics/altIdentifier/wos/WOS:000771940700001; volume:12; issue:2; firstpage:1; lastpage:10; numberofpages:10; journal:METABOLITES; https://hdl.handle.net/2434/1001777
DOI: 10.3390/metabo12020123
Availability: https://hdl.handle.net/2434/1001777; https://doi.org/10.3390/metabo12020123
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.67DC29A3
Database: BASE